Carrier Screening Market Segmented by End-user Industry and Geography – Growth, Trends, and Forecast (2020 – 2027)
Research Reports
Jan 19, 2021
Market Size – USD 1.70 Billion in 2019, Market Growth – CAGR of 17.4%, Market Trends – Growing awareness of carrier screening across the healthcare industry
The market is positively affected by a few key parameters. The main biotechnological companies are trying to introduce and emphasise on a wide variety of affordable and technologically advanced screening test kits along with the solutions in order to keep a tab on the growing emergence of genetic disorders. However, in developing economies, the growing urbanization is leading to changing lifestyles, which often impacts pregnant women during the phase. Hence, in order to initially detect and diagnose a disease, doctors across the globe are emphasising on the usage of carrier screening tests.
Moreover, as a result of the testing kits becoming more advanced and cost-effective, the carrier screening market is predicted to grow significantly throughout the forecast period because of the minimized expenditure on tests and effective efficiency that are propelling the demand for them among people planning a family.
In terms of revenue, North America held the largest market share in 2019 which can be attributed to the increasing number of tests conducted in order to analyze whether an individual is carrying the gene for an inherited disease. The major competitors across the globe are emphasising on the development of healthcare infrastructure. Over the coming years, Asia Pacific is expected to register the highest CAGR of 18.4% throughout the forecasted period as people in India, China, and Australia are becoming aware of genetic diseases and screening tests.
Regional Scope- North America; Europe; Asia Pacific; Central & South America; MEA
For More Details Get FREE Sample Pages of this Research Report@ https://www.emergenresearch.com/request-sample-form/235
Key participants MedGenome Inc., Luminex Corporation, Illumina Inc., Otogenetics Corporation, Myriad Genetics Inc., Thermo Fisher Scientific Inc., Natera Inc., Gene By Gene Ltd., Corporation of America Holdings, and Mount Sinai Genomics Inc., among others.
Technology Outlook (Revenue, USD Billion; 2017-2027)
DNA Sequencing
Polymerase Chain Reaction
Microarrays
Others
End-User Outlook (Revenue, USD Billion; 2017-2027)
Hospitals
Reference Laboratories
Physician Offices and Clinics
Others
Medical Condition Outlook (Revenue, USD Billion; 2017-2027)
Pulmonary Conditions
Hematological Conditions
Neurological Conditions
Others
Browse the full report description @ https://www.emergenresearch.com/industry-report/carrier-screening-market
Table of Content
Chapter 1. Methodology & Sources
1.1. Market Definition
1.2. Research Scope
1.3. Methodology
1.4. Research Sources
1.4.1. Primary
1.4.2. Secondary
1.4.3. Paid Sources
1.5. Market Estimation Technique
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2019-2027
Chapter 3. Key Insights
Chapter 4. Carrier Screening Market Segmentation & Impact Analysis
4.1. Carrier Screening Market Material Segmentation Analysis
4.2. Industrial Outlook
4.2.1. Market indicators analysis
4.2.2. Market drivers analysis
4.2.2.1. Growing emphasize on the non-deadly self-defense
4.2.2.2. Restriction on the firearms in the cross-border conflicts
4.2.2.3. The higher proliferation of the shooting games in sports events
4.2.3. Market restraints analysis
4.2.3.1. Regulatory hurdles & higher cost associated with it
4.2.3.2. Inefficient research methodologies
4.3. Technological Insights
4.4. Regulatory Framework
4.5. Porter’s Five Forces Analysis
4.6. Competitive Metric Space Analysis
4.7. Price trend Analysis
4.8. Covid-19 Impact Analysis
Chapter 5. Carrier Screening Market By Type Insights & Trends, Revenue (USD Billion) (Thousand Units)
5.1. Type Dynamics & Market Share, 2019 & 2027
5.1.1. Pistols
5.1.2. Revolvers
5.1.3. Rifles
5.1.4. Machine Guns
5.1.5. Shotguns
5.1.6. Carbines
5.1.7. Others
Continue…
Thank you for reading our report. For further information or queries about the report or customization options, please get in touch with us. We will ensure your report is tailored according to your requirements.
Related Reports:
Virtual Diagnostics Market Size To Be Worth USD 1,512.2 Million by 2027 Growing at a CAGR of 15.0% | Emergen Research
Anti-Aging Devices Market Size To Be Worth USD 14.22 Billion by 2027 | Emergen Research
Mobile Medical Apps Market Size Worth USD 17.61 Billion by 2027 Growing at a CAGR of 22.9% | Emergen Research
Isoflavones Market Size To Be Worth USD 45.22 Billion by 2027 Growing at a CAGR of 12.9% | Emergen Research
Farm Management Software and Services Market To Be Worth USD 3,015.5 Million by 2027 | Emergen Research
Activated Carbon Market Size Worth USD 14.07 Billion by 2027 Growing at a CAGR of 9.6% | Emergen Research
Cardiac Monitoring & Cardiac Rhythm Management Devices Market To Be Worth USD 29.32 Billion by 2027 | Emergen Research
Neurostimulation Devices Market To Reach USD 13.70 Billion by 2027 Growing at a CAGR of 12.6% | Emergen Research
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: [email protected]
Facebook | LinkdIn | Twitter | Blogs
Tags:
, Reportedtimes, iCN Internal Distribution, Research Newswire, English




